Kekst CNC works EQT private equity firm’s $9.6B sale of its Aldevron plasma DNA unit to Danaher Corp.

Based in Fargo, ND, Aldevron’s proteins are used in vaccines, gene and cell therapy, gene editing and diagnostic applications. Its products played a key role in developing COVID-19 vaccines.

Eric Liu, global head of healthcare at EQT, said his firm is proud of supporting Aldevron during the past six years in delivering the highest quality products that help improve patient lives across the world.

Kevin Ballinger, CEO of Aldevron, said EQT was a great financial partner, but Danaher is an excellent strategic fit.

Kekst CNC’s Daniel Yunger, Maddie Sewani and Natalie Shutts advised EQT.